Journal
FREE RADICAL BIOLOGY AND MEDICINE
Volume 45, Issue 12, Pages 1674-1681Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2008.09.004
Keywords
Genomic instability; Amifostine; WR-1065; High-LET radiation; Delayed effects; Radio-protection
Funding
- NASA [NNJ05HE73G]
- DOE [DE-FG-01-04ER04-21]
- NIH [P30-CA086862]
Ask authors/readers for more resources
Compounds that can protect cells from the effects of radiation are important for clinical use, in the event of an accidental or terrorist-generated radiation event, and for astronauts traveling in space. One of the major concerns regarding the use of radio-protective agents is that they may protect cells initially, but predispose surviving cells to increased genomic instability later. In this study we used WR-1065, the active metabolite of amifostine, to determine how protection from direct effects of high- and low-LET radiation exposure influences genomic stability. When added 30 min before irradiation and in high concentrations, WR-1065 protected cells from immediate radiation-induced effects as well as from delayed genomic instability. Lower, nontoxic concentrations of WR-1065 did not protect cells from death; however, it was effective in significantly decreasing delayed genomic instability in the progeny of irradiated cells. The observed increase in manganese superoxide dismutase protein levels and activity may provide an explanation for this effect. These results confirm that WR-1065 is protective against both low- and high-LET radiation-induced genomic instability in surviving cells. (C) 2008 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available